Aspartylglycosaminuria with Treatment and Prevention


h1 September 8th, 2008
Aspartylglycosaminuria (AGU) are ingeboren an error of metabolism which is caused by inadequate activity of the enzyme aspartylglucosaminidase. It occurs as a result of deficient activity of a particular enzyme, leading to the accumulation of metabolic products in the body. Aspartylglycosaminuria mutations occur in the gene for glycosylasparaginase, the enzyme necessary for hydrolysis of the protein oligosaccharide linkage in Asn-linked glycoprotein substrates undergoing metabolic turnover. Major symptoms may include coarse facial features, spine and eye deformities, behavior problems and mental retardation. Without this enzyme, used materials cannot be completely broken down and remain stored in the body, causing progressive damage to cells. Babies may show little sign of the disease, but as more and more cells become damaged, symptoms start to appear.

Aspartylglycosaminuria are ingeboren an error of metabolism, and one of the lysosomal rise sickness. It becomes clearly after the zuigeling a couple is months old. It is a member of finnish disease heritage, a group of diseases or syndromes caused by mutation in a single gene characterized by higher frequency in Finland than the rest of the world. If an adult carrying the abnormal gene has a partner who also is a carrier, there will be a one in four chance with every pregnancy that the child will inherit the defective gene from each parent and will suffer from the disease. There is a two in three chance that unaffected brothers and sisters of aspartylglycosaminuria sufferers will be carriers. Deficiency of the aspartylglucosaminidase, an enzyme which cleaves the N-acetyl-glucosamine-asparagine linkage of oligosaccharide chains in glycoprotein and glycopeptide metabolism.